A new coronavirus accelerator
Three major groups are putting $125 million into a new effort to develop treatments against the novel coronavirus. The Bill & Melinda Gates Foundation, the Wellcome Trust, and Mastercard’s charitable arm announced this morning that they’re launching the Covid-19 Therapeutics Accelerator.
Even $125 million likely won’t be enough to fully develop one drug, let alone multiple drugs. But the president of the Gates Foundation, Trevor Mundel, told STAT’s Matt Herper that he hopes the accelerator might be able to work with traditional drug companies and governments and the World Health Organization to speed up the process.
“The companies that I've spoken to, including some of the big companies, one of their abiding fears is that anything they do in this area would be seen as some kind of price-gouging," Mundel said.
Read more.
Even $125 million likely won’t be enough to fully develop one drug, let alone multiple drugs. But the president of the Gates Foundation, Trevor Mundel, told STAT’s Matt Herper that he hopes the accelerator might be able to work with traditional drug companies and governments and the World Health Organization to speed up the process.
“The companies that I've spoken to, including some of the big companies, one of their abiding fears is that anything they do in this area would be seen as some kind of price-gouging," Mundel said.
Read more.
.png)
No hay comentarios:
Publicar un comentario